Global Biosurgery Market
Размер рынка в млрд долларов США
CAGR :
% 
USD
13.76 Billion
USD
22.26 Billion
2023
2031
 Прогнозируемый период |
2024 –2031 |
 Размер рынка (базовый год) |
USD 13.76 Billion |
 Размер рынка (прогнозируемый год) |
USD 22.26 Billion |
 CAGR |
% |
| Основные игроки рынка |
|
>Global Biosurgery Market Segmentation, By Product (Bone-Graft Substitutes, Soft-Tissue Attachments, Hemostatic Agents, Surgical Sealants and Adhesives, Adhesion Barriers and Staple-Line Reinforcement Agents), Application (General Surgery, Cardiovascular Surgery, Orthopaedic Surgery, Neurological Surgery, Reconstructive Surgery, Gynaecological Surgery, Thoracic Surgery and Urological Surgery), End-User (Hospitals, Clinics and Others) - Industry Trends and Forecast to 2031.
Biosurgery Market Analysis
Biosurgery products are utilised to restore weaker and injured tissues and bones in a variety of operations. In surgical treatment, wound and tissue management, and regenerative healing, biosurgery has ushered in a new era. With the correct balance of biologics and synthetics, it has even opened new potential in regenerative repair.
Biosurgery Market Size
Global biosurgery market size was valued at USD 13.76 billion in 2023 and is projected to reach USD 22.26 billion by 2031, with a CAGR of 6.2% during the forecast period of 2024 to 2031.
Report Scope and Market Segmentation
|
Attributes |
Biosurgery Key Market Insights |
|
Segmentation |
|
|
Countries Covered |
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America |
|
Key Market Players |
Baxter (US), BD (US), Johnson & Johnson Services, Inc. (US), Medtronic (US), Sanofi (France), B. Braun Melsungen AG (Germany), CryoLife, Inc. (US), Stryker Corporation (US), Hemostasis, LLC (US), Integra LifeSciences Corporation (US), Pfizer Inc. (US), CSL Limited (Australia), Exactech, Inc. (US), RTI Surgical Holdings, Inc. (US), Getinge AG (Sweden), SAMYANG HOLDINGS CORPORATION. (US), AROA BIOSURGERY LIMITED (New Zealand), TELA Bio, Inc. (US), Tissue Regenix (UK), Osiris Therapeutics, Inc. (US) |
|
Market Opportunities |
|
Biosurgery Market Definition
Biosurgery is the practise of cleaning a wound or contaminated area with live organisms like as larvae or maggots. The treatment is centuries old, yet it has remained popular in society due to the benefits it provides. The living organisms utilised in this treatment eat up the cleansed region as well as bad bodily growth, while cleansing away the beneficial material. Tissue management and regenerative tissue healing are other applications of the treatment. Maggot therapy and larval therapy are other terms for the same treatment.
Biosurgery Market Dynamics
Drivers
- Rise in the cases of surgeries
The number of procedures requiring long operating hours has increased as the number of accidents has increased. As a result, the demand for appropriate blood loss management products during surgical procedures has skyrocketed.
- A strong concentration on research and development
Biosurgery has become more popular as a result of technical breakthroughs and innovations in healthcare facilities. As an alternative to traditional open surgery, biosurgery plays a critical role here. As a result, technical improvements have occurred.
- Growing demand for effective blood loss management in patients
The biosurgery market is developing due to the increasing acceptance of biosurgery products over conventional goods and their effectiveness in managing blood loss.
Opportunities
In addition, the rise in the health awareness, expanding healthcare expenditure, growing medical tourism, and fast improving healthcare infrastructure is further estimated to provide potential opportunities for the growth of the biosurgery market in the coming years.
Restraints/Challenges
On the other hand, the increased cost of biosurgery products and the growing cost of surgical procedures is further projected to impede the growth in the targeted period. However, the strict regulatory framework might further challenge the growth of the biosurgery market in the near future.
This biosurgery market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the biosurgery market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on Biosurgery Market
The COVID-19 had a negative impact on the biosurgery market. The implementation of social distancing norms and lockdown rules in various regions brought bans and limitations on various elective medical procedures and elective surgeries. Also the surgical procedures have witnessed decline and were expected to increase in the third quarter of 2021. In the latter half of the forecast period, the demand for biosurgery will rise again owing to leniency on the restrictions.
Biosurgery Market Scope
The biosurgery market is segmented on the basis of product, application and end user. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product
- Bone-Graft Substitutes
- Demineralized
- Bone Matrix
- Synthetic Bone Grafts
- Bone Morphogenetic Proteins
- Others
- Soft-Tissue Attachments
- Synthetic Meshes
- Biological Meshes
- Hemostatic Agents
- Thrombin-Based Hemostatic Agents
- Oxidized Regenerated Cellulose-Based Hemostatic Agents
- Combination Hemostatic
- Surgical Sealants and Adhesives
- Adhesion Barriers
- Staple-Line Reinforcement Agents
Application
- Pediatrics
- Adults
- Elderly
End User
- Hospitals
- Clinics
- Others
Biosurgery Market Regional Analysis
The biosurgery market is analysed and market size insights and trends are provided by country, product, application and end user as referenced above.
The countries covered in the biosurgery market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the biosurgery market due to the long-standing healthcare industry. Furthermore, the rise in the incidence of obesity and cardiovascular diseases will further boost the growth of the biosurgery market in the region during the forecast period.
Asia-Pacific is projected to observe significant amount of growth in the biosurgery market due to the developments in the healthcare facilities and reimbursement policies in advancing economies. Moreover, the rise in the awareness associated to the advanced surgical procedures is further anticipated to propel the growth of the biosurgery market in the region in the coming years.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The biosurgery market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for biosurgery market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the biosurgery market. The data is available for historic period 2010-2020.
Biosurgery Market Share
The biosurgery market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to biosurgery market.
Biosurgery Market Leaders Operating in the Market Are:
- Baxter (US)
- BD (US)
- Johnson & Johnson Services, Inc. (US)
- Medtronic (US)
- Sanofi (France)
- B. Braun Melsungen AG (Germany)
- CryoLife, Inc. (US)
- Stryker Corporation (US)
- Hemostasis, LLC (US)
- Integra LifeSciences Corporation (US)
- Pfizer Inc. (US)
- CSL Limited (Australia)
- Exactech, Inc. (US)
- RTI Surgical Holdings, Inc. (US)
- Getinge AG (Sweden)
- SAMYANG HOLDINGS CORPORATION. (US)
- AROA BIOSURGERY LIMITED (New Zealand)
- TELA Bio, Inc. (US)
- Tissue Regenix (UK)
- Osiris Therapeutics, Inc. (US)
Latest Development in Biosurgery Market
- Peri-Strips Dry with Veritas Collagen Matrix product with Secure Grip received 510 (k) clearance from the US FDA in February 2020. The product is a staple line reinforcing agent that is used to control bleeding during bariatric and other surgical procedures.
- In 2019, Grifols had launched plasma protein-based biosurgery product named VISTASEAL. The product is a fibrin sealant designed particularly for biosurgical bleeding-control consisting of a combination of two plasma proteins.
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Интерактивная панель анализа данных
- Панель анализа компании для возможностей с высоким потенциалом роста
- Доступ аналитика-исследователя для настройки и запросов
- Анализ конкурентов с помощью интерактивной панели
- Последние новости, обновления и анализ тенденций
- Используйте возможности сравнительного анализа для комплексного отслеживания конкурентов
Методология исследования
Сбор данных и анализ базового года выполняются с использованием модулей сбора данных с большими размерами выборки. Этап включает получение рыночной информации или связанных данных из различных источников и стратегий. Он включает изучение и планирование всех данных, полученных из прошлого заранее. Он также охватывает изучение несоответствий информации, наблюдаемых в различных источниках информации. Рыночные данные анализируются и оцениваются с использованием статистических и последовательных моделей рынка. Кроме того, анализ доли рынка и анализ ключевых тенденций являются основными факторами успеха в отчете о рынке. Чтобы узнать больше, пожалуйста, запросите звонок аналитика или оставьте свой запрос.
Ключевой методологией исследования, используемой исследовательской группой DBMR, является триангуляция данных, которая включает в себя интеллектуальный анализ данных, анализ влияния переменных данных на рынок и первичную (отраслевую экспертную) проверку. Модели данных включают сетку позиционирования поставщиков, анализ временной линии рынка, обзор рынка и руководство, сетку позиционирования компании, патентный анализ, анализ цен, анализ доли рынка компании, стандарты измерения, глобальный и региональный анализ и анализ доли поставщика. Чтобы узнать больше о методологии исследования, отправьте запрос, чтобы поговорить с нашими отраслевыми экспертами.
Доступна настройка
Data Bridge Market Research является лидером в области передовых формативных исследований. Мы гордимся тем, что предоставляем нашим существующим и новым клиентам данные и анализ, которые соответствуют и подходят их целям. Отчет можно настроить, включив в него анализ ценовых тенденций целевых брендов, понимание рынка для дополнительных стран (запросите список стран), данные о результатах клинических испытаний, обзор литературы, обновленный анализ рынка и продуктовой базы. Анализ рынка целевых конкурентов можно проанализировать от анализа на основе технологий до стратегий портфеля рынка. Мы можем добавить столько конкурентов, о которых вам нужны данные в нужном вам формате и стиле данных. Наша команда аналитиков также может предоставить вам данные в сырых файлах Excel, сводных таблицах (книга фактов) или помочь вам в создании презентаций из наборов данных, доступных в отчете.
